Intra-Cellular Therapies to Present at the 45th Annual Goldman Sachs Global Healthcare Conference

Rhea-AI Summary

Intra-Cellular Therapies (Nasdaq: ITCI), a biopharmaceutical company focusing on CNS disorder therapeutics, announced that its CEO, Sharon Mates, Ph.D., will present at the 45th Annual Goldman Sachs Global Healthcare Conference. The presentation is scheduled for June 11, 2024, at 10:00 a.m. ET in Miami, FL. The live and archived webcast will be available under the 'Events & Presentations' section of the company's website. Attendees are advised to log in 5-10 minutes prior to the event to register and install any necessary software.

Positive

• Intra-Cellular Therapies is presenting at a prestigious event, indicating recognition in the healthcare sector.
• The presence of CEO Sharon Mates, Ph.D., highlights strong leadership and commitment.
• Availability of live and archived webcast increases transparency and accessibility for investors.

Negative

• There is no new financial or clinical data presented in this announcement.
• The event itself may not directly influence stock performance without substantive updates.

NEW YORK, June 10, 2024 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders, today announced that Sharon Mates, Ph.D., Chief Executive Officer and Chairman, is scheduled to present at the 45th Annual Goldman Sachs Global Healthcare Conference on Tuesday, June 11, 2024 at 10:00 a.m. ET in Miami, FL.

The live and archived webcast can be accessed under "Events & Presentations" in the Investor Relations section of the Company's website at www.intracellulartherapies.com. Please log in approximately 5-10 minutes prior to the event to register and to download and install any necessary software.

About Intra-Cellular Therapies
Intra-Cellular Therapies is a biopharmaceutical company founded on Nobel prize-winning research that allows us to understand how therapies affect the inner-workings of cells in the body. The company leverages this intracellular approach to develop innovative treatments for people living with complex psychiatric and neurologic diseases. For more information, please visit www.intracellulartherapies.com.

Contact:
Intra-Cellular Therapies, Inc.
Juan Sanchez, M.D.
Vice President, Corporate Communications and Investor Relations
646-440-9333

Burns McClellan, Inc.
Cameron Radinovic
cradinovic@burnsmc.com
646-930-4406

FAQ

When will Intra-Cellular Therapies present at the Goldman Sachs Global Healthcare Conference?

Intra-Cellular Therapies will present on June 11, 2024, at 10:00 a.m. ET.

Where can I access the live and archived webcast of Intra-Cellular Therapies' presentation?

The webcast will be available under the 'Events & Presentations' section on the company's website.

Who will be presenting at the 45th Annual Goldman Sachs Global Healthcare Conference for Intra-Cellular Therapies?

Sharon Mates, Ph.D., CEO and Chairman of Intra-Cellular Therapies, will be presenting.

What is the focus of Intra-Cellular Therapies?

Intra-Cellular Therapies focuses on developing and commercializing therapeutics for central nervous system (CNS) disorders.

What is the stock symbol for Intra-Cellular Therapies?

The stock symbol for Intra-Cellular Therapies is ITCI.